Condition: Cerebrovascular Disorders · Intracranial Hemorrhages · Intracranial Hemorrhage · Sponsor: The Second Hospital of Anhui Medical University
The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.
This description comes directly from the study's public registry record.
Qi Li · +8618623511778 · qili_md@126.com
Always discuss trial participation with your own doctor first.
| Anqing First People's Hospital of Anhui Province | Anqing, Anhui, China | Recruiting |
| Fuyang City Sixth People's Hospital | Fuyang, Anhui, China | Recruiting |
| Fuyang Hospital of Anhui Medical University | Fuyang, Anhui, China | Recruiting |
| Fuyang People's Hospital | Fuyang, Anhui, China | Recruiting |
| Hefei Eighth People's Hospital | Hefei, Anhui, China | Recruiting |
| Hefei First People's Hospital | Hefei, Anhui, China | Recruiting |
| The Second Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| Huainan Xinhua Hospital | Huainan, Anhui, China | Recruiting |
| The First Affiliated Hospital of Anhui University of Science and Technology (Huainan First People's Hospital) | Huainan, Anhui, China | Recruiting |
| Huoqiu First People's Hospital | Lu'an, Anhui, China | Recruiting |
| Shucheng People's Hospital | Lu'an, Anhui, China | Recruiting |
| Si County People's Hospital | Suzhou, Anhui, China | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07088250